The Calcium Channel Blocker Verapamil Inhibits Oxidative Stress Response in Candida albicans

Mycopathologia

Volumn 177, Issue 3-4, 2014, Pages 167-177

  Yu, Qilin ^a   Xiao, Chenpeng ^a   Zhang, Kailun ^a   Jia, Chang ^a   Ding, Xiaohui ^a   Zhang, Bing ^a   Wang, Yu ^a   Li, Mingchun ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Calcium signaling; Candida albicans; Oxidative stress; Verapamil

Indexed keywords

ANTIFUNGAL AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; FUNGAL PROTEIN; HYDROGEN PEROXIDE; VERAPAMIL;

ANTAGONISTS AND INHIBITORS; CANDIDA ALBICANS; CANDIDIASIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; OXIDATIVE STRESS;

ANTIFUNGAL AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CANDIDA ALBICANS; CANDIDIASIS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; VERAPAMIL;

EID: 84921935064     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-014-9735-7     Document Type: Article

References (40)

1. Dalle F, Wächtler B, L’Ollivier C, Holland G, Bannert N, Wilson D, Labruère C, Bonnin A, Hube B. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol. 2010;12:248–71.
2. Ferreira AV, Prado CG, Carvalho RR, Dias KST, Dias ALT. Candida albicans and non-C.albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia. 2013;175:265–72.
3. Mavor AL, Thewes S, Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets. 2005;6:863–74.
4. Sudbery P, Gow NAR, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12:317–24.
5. Kumamoto CA, Vinces MD. Alternative Candida albicans lifestyles: growth on surfaces. Ann Rev Microbiol. 2005;59:113–33.
6. Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M, Monk BC. Candida albicans drug resistance: another way to cope with stress. Microbiology. 2007;153:3211–7.
7. LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AA, Perfect JR, Cowen LE. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 2010;6:e1001069.
8. Zhang XT, de Micheli M, Coleman ST, Sanglard D, Moye-Rowley WS. Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p. Mol Microbiol. 2000;36:618–29.
9. Lewis LE, Bain JM, Lowes C, Gillespie C, Rudkin FM, Gow NAR, Erwig LP. Stage specific assessment of Candida albicans phagocytosis by macrophages identifies cell wall composition and morphogenesis as key determinants. PLoS Pathog. 2012;8:e1002578.
10. Netea MG, Brown GD, Kullberg BJ, Gow NAR. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol. 2008;6:67–78.
11. Kusch H, Engelmann S, Albrecht D. Proteomic analysis of the oxidative stress responses in Candida albicans. Proteomics. 2007;7:686–97.
12. Jamieson DJ, Stephen DWS, Terriere EC. Analysis of the adaptive oxidative stress response of Candida albicans. FEMS Microbiol Lett. 1996;138:83–8.
13. Wang Y, Cao YY, Jia XM, Cao YB, Gao PH, Fu XP, Ying K, Chen WS, Jiang YY. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radical Biol Med. 2006;40:1201–9.
14. +-ATPase in Saccharomyces cerevisiae cells. Cell Calcium. 2012;51:72–81.
15. 2+-ATPase, is required for glycosylation and virulence. J Biol Chem. 2005;280:23408–15.
16. Karababa M, Valentino E, Pardini G. CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol. 2006;59:1429–51.
17. Sanglard D, Ischer F, Marchetti O, Entenza J, Bille J. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol. 2003;48:959–76.
18. Yu Q, Wang H, Cheng X, Xu N, Ding X, Xing L, Li M. Roles of Cch1 and Mid1 in morphogenesis, oxidative stress response and virulence in Candida albicans. Mycopathologia. 2012;174:359–69.
19. Ding X, Yu Q, Xu N, Wang Y, Cheng X, Qian K, Zhao Q, Zhang B, Xing L, Li M. Ecm7, a regulator of HACS, functions in calcium homeostasis maintenance, oxidative stress response and hyphal development in Candida albicans. Fungal Genet Biol. 2013;57:23–32.
20. Strigun A, Noor F, Pironti A, Niklas J, Yang TH, Heinzle E. Metabolic flux analysis gives an insight on verapamil induced changes in central metabolism of HL-1 cells. J Biotechnol. 2011;155:299–307.
21. Simpson WG. The calcium channel blocker verapamil and cancer chemotherapy. Cell Calcium. 1985;6:449–67.
22. Teng J, Goto R, Iida K, Kojima I, Iida H. Ion-channel blocker sensitivity of voltage-gated calcium-channel homologue Cch1 in Saccharomyces cerevisiae. Microbiology. 2008;154:3775–81.
23. Yu Q, Ding X, Xu N, Cheng X, Qian K, Zhang B, Xing L, Li M. In vitro activity of verapamil singly and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Int J Antimicrob Agents. 2013;41:179–82.
24. Dantas AS, Patterson MJ, Smith DA, MacCallum DM, Erwig LP, Morgan BA, Quinn J. Thioredoxin regulates multiple hydrogen peroxide-induced signaling pathways in Candida albicans. Mol Cell Biol. 2010;30:4550–63.
25. Wang H, Liang Y, Zhang B, Zheng W, Xing L, Li M. Alkaline stress triggers an immediate calcium fluctuation in Candida albicans mediated by Rim101p and Crz1p transcription factors. FEMS Yeast Res. 2011;11:430–9.
26. Yu Q, Wang H, Xu N, Cheng X, Wang Y, Zhang B, Xing L, Li M. Spf1 strongly influences calcium homeostasis, hyphal development, biofilm formation and virulence in Candida albicans. Microbiology. 2012;158:2272–82.
27. 2+ release in the yeast Saccharomyces cerevisiae. FEBS J. 2010;277:4027–38.
28. Nakagawa Y, Kanbe T, Mizuguchi I. Disruption of the human pathogenic yeast Candida albicans catalase gene decreases survival in mouse-model infection and elevates susceptibility to higher temperature and to detergents. Microbiol Immunol. 2003;47:395–403.
29. Hwang CS, Rhie GE, Oh JH, Huh WK, Yim HS, Kang SO. Copper- and zinc-containing superoxide dismutase (Cu/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology. 2002;148:3705–13.
30. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007;17:422–7.
31. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA. 1991;88:3671–5.
32. Zitka O, Skalickova S, Gumulec J, Masarik M, Adam V, Hubalek J, Trnkova L, Kruseova J, Eckschlager T, Kizek R. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett. 2012;4:1247–53.
33. Reddi AR, Jensen LI, Naranuntarat A, Rosenfeld L, Leung E, Shah R, Culotta VC. The overlapping roles of manganese and Cu/Zn SOD in oxidative stress protection. Free Radical Biol Med. 2009;46:154–62.
34. Laun P, Pichova A, Madeo F, Fuchs J, Ellinger A, Kohlwein S, Dawes I, Frohlich KH, Breitenbach M. Aged mother cells of Saccharomyces cerevisiae show markers of oxidative stress and apoptosis. Mol Microbiol. 2001;39:1166–73.
35. Cheng J, Park TS, Chio LC, Fischl AS, Ye XS. Induction of apoptosis by sphingoid long-chain bases in Aspergillus nidulans. Mol Cell Biol. 2003;23:163–77.
36. Leiter E, Szappanos H, Oberparleiter C, Kaiserer L, Csernoch L, Pusztahelyi T, Emri T, Pocsi I, Salvenmoser W, Marx F. Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype. Antimicrob Agents Chemother. 2005;9:2445–53.
37. Yu Q, Wang F, Zhao Q, Chen J, Zhang B, Ding X, Wang H, Yang B, Lu G, Zhang B, Li M. A novel role of the vacuolar calcium channel Yvc1 in stress response, morphogenesis and pathogenicity of Candida albicans. Int J Med Microbiol. 2013. doi:10.1016/j.ijmm.2013.11.022.
38. Krevsky B, Maurer AH, Niewiarowski T, Cohen S. Effect of verapamil on human intestinal transit. Dig Dis Sci. 1992;37:919–24.
39. Pennock GD, Dalton WS, Roeske WR, Appleton CP, Mosley K, Plezia P, Miller TP, Salmon SE. Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J Natl Cancer Inst. 1991;83:105–10.
40. Wilson RB, Davis DA, Mitchell AAP. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol. 1999;18:1868–74.